BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CMC Biologics 

22021 20th Avenue SE

Bothell  Washington  98021  U.S.A.
Phone: 425-485-1900 Fax: 425-486-0300


SEARCH JOBS




Industry
Services






 Company News
CMC Biologics Enters Into Commercial Supply Agreement With Portola Pharmaceuticals, Inc. For Manufacturing Of First-In-Class Factor Xa Inhibitor Antidote Andexanet Alfa 7/3/2014 6:29:56 AM
CMC Biologics And MacroGenics, Inc. (MGNX) Enter Into Process Validation And Clinical Manufacturing Agreement For Commercialization Of Next-Generation Oncology Product Candidate 6/17/2014 11:56:31 AM
CMC Biologics And MacroGenics, Inc. (MGNX) Enter Into A Process Development And Manufacturing Agreement For Oncology Product Candidate 5/6/2014 9:32:19 AM
CMC Biologics Wins 2014 CMO Leadership Awards For Innovation, Quality And Reliability 4/3/2014 8:51:09 AM
Jesper Bramming, Former A.P. Moller Executive, Joins The CMC Biologics Executive Management Team As Chief Financial Officer 1/8/2014 9:19:36 AM
CMC Biologics And Oncosynergy Enter Into Agreement To Develop And Manufacture Material For IND Enabling Studies And Phase I Clinical Trials 12/17/2013 10:31:32 AM
CMC Biologics Achieves Authorization for cGMP Commercial Manufacturing by the Danish Medicines Agency 10/15/2013 9:20:49 AM
CMC Biologics and RuiYi (formerly Anaphore) Enter into an Agreement for Development of a Novel Anti-IL-6 Monoclonal Antibody 5/14/2013 9:28:56 AM
CMC Biologics Wins 2013 CMO Leadership Award for Innovation, Quality and Reliability 3/19/2013 9:48:44 AM
CMC Biologics Establishes Commercial Presence in Japan through Strategic Agreement With Innomedica 9/12/2012 9:46:49 AM
123